The mice from the sequential infection group and 4 out of 5 mice from the WIV vaccination group developed anti-NA antibodies, while only 2 out of 5 mice from the sequential SU vaccination group did so and levels of anti-NA antibody were low (Figure S1B). This evidence concerns the gene XK and infection.